These results corroborate previous basic studies highlighting gut–liver axis dysregulation in diet models of MASLD/MASH in mice,[18], [19], [20] as well as more recent work reporting reduction of AMPs expression in the ileum of cirrhotic patients.21 This evidence concerns the gene ADSL and metabolic dysfunction-associated steatotic liver disease.